Literature DB >> 16263435

Epidemiology and bacteriology of bacterial pneumonias.

P T Heath1.   

Abstract

An understanding of the epidemiology and bacteriology of pneumonia in childhood is frustrated by the difficulties in making an aetiological diagnosis in young children. Incidence figures for community-acquired pneumonia are derived from the 1970s and 1980s and suggest that the incidence is higher in young children than in older children: approximately 40/1000/year <5 years of age and 15/1000/year aged 5-14 years. Certain pathogens are associated with pneumonia in different age groups, Mycoplasma pneumoniae and Chlamydia pneumoniae are more commonly implicated in older age groups and viruses in younger age groups. The most common bacterium, Streptococcus pneumoniae is less influenced by age. The mortality from community-acquired pneumonia in developed countries appears to be very low. The range of potential bacterial pathogens associated with nosocomial pneumonia and with pneumonia in the immunosuppressed child is wider with Gram-negative aerobic bacilli the most frequent isolate.

Entities:  

Mesh:

Year:  2000        PMID: 16263435     DOI: 10.1053/prrv.2000.0001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  8 in total

1.  Community-acquired pneumonia in children aged 2 months to 5 years: application of the WHO guidelines in a developed country setting (Switzerland).

Authors:  Mirjam Dirlewanger; Jean-Daniel Krahenbuhl; Sergio Fanconi; Bernard Vaudaux; Mario Gehri
Journal:  Eur J Pediatr       Date:  2002-08       Impact factor: 3.183

2.  Simultaneous detection of Chlamydophila pneumoniae and Mycoplasma pneumoniae by use of molecular beacons in a duplex real-time PCR.

Authors:  Karolina Gullsby; Martin Storm; Kåre Bondeson
Journal:  J Clin Microbiol       Date:  2007-12-19       Impact factor: 5.948

3.  Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease.

Authors:  Martin C J Kneyber; Heleen Blussé van Oud-Alblas; Margreet van Vliet; Cuno S P M Uiterwaal; Jan L L Kimpen; Adrianus J van Vught
Journal:  Intensive Care Med       Date:  2005-04-01       Impact factor: 17.440

4.  Verification of the ProPneumo-1 assay for the simultaneous detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in clinical respiratory specimens.

Authors:  Rachel R Higgins; Ernesto Lombos; Patrick Tang; Karl Rohoman; Anne Maki; Shirley Brown; Frances Jamieson; Steven J Drews
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-03-10       Impact factor: 3.944

5.  Impact of viral infections in children with community-acquired pneumonia: results of a study of 17 respiratory viruses.

Authors:  Susanna Esposito; Cristina Daleno; Giulia Prunotto; Alessia Scala; Claudia Tagliabue; Irene Borzani; Emilio Fossali; Claudio Pelucchi; Nicola Principi
Journal:  Influenza Other Respir Viruses       Date:  2012-02-13       Impact factor: 4.380

6.  Comparison between diagnosis and treatment of community-acquired pneumonia in children in various medical centres across Europe with the United States, United Kingdom and the World Health Organization guidelines.

Authors:  Vytautas Usonis; Rimvydas Ivaskevicius; Javier Diez-Domingo; Susanna Esposito; Oana G Falup-Pecurariu; Adam Finn; Fernanda Rodrigues; Vana Spoulou; George A Syrogiannopoulos; David Greenberg
Journal:  Pneumonia (Nathan)       Date:  2016-05-02

7.  An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice.

Authors:  Shizuka Hartenbach; Marie Daoud-El Baba; Wilfried Weber; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2007-10-18       Impact factor: 16.971

8.  Etiology of community-acquired pneumonia in hospitalized children based on WHO clinical guidelines.

Authors:  Manon Cevey-Macherel; Annick Galetto-Lacour; Alain Gervaix; Claire-Anne Siegrist; Jacques Bille; Béatrice Bescher-Ninet; Laurent Kaiser; Jean-Daniel Krahenbuhl; Mario Gehri
Journal:  Eur J Pediatr       Date:  2009-02-24       Impact factor: 3.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.